Ara
Toplam kayıt 109, listelenen: 71-80
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
(Wiley, 2016)
What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...
Right Heart Thrombi Treatment
(Elsevier Science Inc, 2017)
Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics
(Lippincott Williams & Wilkins, 2015)
Creatine supplementation on cardiac autonomic functions
(Wiley, 2017)
Peripartum cardiomyopathy in the ED
(W B Saunders Co-Elsevier Inc, 2015)
Bridging anticoagulation in patients with mechanical heart valves
(Elsevier Ireland Ltd, 2017)
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
(Turkish Soc Cardiology, 2016)
Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ...
Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor
Kounis syndrome and antibiotics
(K Faisal Spec Hosp Res Centre, 2014)
PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)
(Sage Publications Inc, 2017)
Introduction: Inappropriate use of oral anticoagulants (OACs) have not been well investigatedand, however, may be frequent in real-world practice in patients with nonvalvular atrial fibrillation (NVAF). This study was ...